Author

Ruth Álvarez

Spanish National Cancer Research CentreORCID 0000-0003-0141-4881Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Alejandra López-GarcíaiD· 1 shared Blanca Rosas-PéreziD· 1 shared Bruno SáinziD· 1 shared Carmen E. GuerraiD· 1 shared Carmen G. LechugaiD· 1 shared Domingo Acosta· 1 shared Eduardo J. CaleirasiD· 1 shared Elena Zamorano-DomíngueziD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alejandra López-GarcíaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedDec 2, 2025

A TARGETED COMBINATION THERAPY ACHIEVES EFFECTIVE PANCREATIC CANCER REGRESSION AND PREVENTS TUMOR RESISTANCE

Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou…·Mariano Barbacid

This paper shows that combining three KRAS signaling pathway inhibitors effectively regresses pancreatic tumors and prevents resistance in preclinical models.

25 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky